Strategic Analysis of Fluid Extravasations to Improve Vascular Safety (SAFE IVS).
Purpose Peripheral intravenous infiltration and extravasation injuries (PIVIEs) in pediatric patients are a significant yet underrecognized source of preventable harm, often due to inconsistent detection and limited standardization. This study implemented a structured quality improvement initiative...
| Publicado en: | American Journal of Health-System Pharmacy Vol. 83; no. 14; pp. 775 - 787 |
|---|---|
| Autores principales: | , , , |
| Formato: | research tables/charts Journal Article |
| Publicado: |
Oxford University Press / USA
Jul2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=195186120&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 195186120 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 10792082 1X3 jtl: American Journal of Health-System Pharmacy issn: 10792082 maglogo: N pubinfo: dt: Jul2026 vid: 83 iid: 14 pid: 622 pub: Oxford University Press / USA artinfo: ui: 195186120 195186120 195186120 10.1093/ajhp/zxag023 195186120 ppf: 775 ppct: 12 formats: tig: atl: Strategic Analysis of Fluid Extravasations to Improve Vascular Safety (SAFE IVS). aug: au: MacKinnon, Taylor Pounders, Kaitlin Dienerc, Kathy Doellner, Courtney affil: Cleveland Clinic, Mayfield Heights, OH, USA sug: subj: Program Implementation Quality Improvement Infusions, Intravenous Adverse Effects Extravasation of Diagnostic and Therapeutic Materials Prevention and Control Patient Safety Pediatric Care Early Diagnosis Hospitals, Pediatric Hospital Programs Program Evaluation Human Prospective Studies Descriptive Statistics Risk Management Catheterization, Peripheral Adverse Effects Antidotes Administration and Dosage Documentation Decision Making, Clinical Hyaluronidase Vascular Access Devices Adverse Effects ab: Purpose Peripheral intravenous infiltration and extravasation injuries (PIVIEs) in pediatric patients are a significant yet underrecognized source of preventable harm, often due to inconsistent detection and limited standardization. This study implemented a structured quality improvement initiative to enhance early detection, classification, and management of PIVIEs at C.S. Mott Children's Hospital, supporting the institution's goal of zero preventable harm. Summary This single-center, prospective quality improvement study was conducted at a 347-bed academic pediatric hospital from January 2023 to December 2024. All patients with a documented PIVIE were included. Key interventions included creation of a multidisciplinary PIVIE Prevention Task Force, standardized event review, development of a pediatric infusion agent risk classification algorithm, and updated antidote protocols. Outcomes measured included PIVIE reporting volume, antidote timeliness, and classification documentation. Descriptive statistics were used to assess trends. Following intervention, 628 PIVIEs were reported—a 465.8% increase from 111 events reported during the 2021-2022 period. Implementation of an institutional standard of care form and a centralized database improved documentation and expedited antidote administration. A pediatric-specific classification system was developed and applied to over 90 high-use agents, enabling risk-based clinical decision-making. Conclusion Interdisciplinary, structured interventions markedly improved reporting, documentation, and treatment of pediatric PIVIEs. Adoption of standardized classification tools and review processes may help hospitals reduce IV-related complications. Policymakers and accrediting bodies should consider incentivizing pediatric vascular safety metrics, supporting integration of pediatric-specific risk frameworks, and encouraging cross-institutional data sharing to drive broader improvements in care. pubtype: Academic Journal doctype: research tables/charts Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|